Stock Analysis: Chemical Works Of Gedeon Richter

Space Grey Ipad Air With Graph on Brown Wooden Table

Image Source: Pexels


Founded in 1901 and headquartered in Budapest, Hungary Chemical Works of Gedeon Richter (GEDSF) discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products in Europe, the Asia Pacific, North and Latin America, and internationally.

The company was formerly known as Gedeon Richter Ltd. Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

Three key data points gauge Chemical Works of Gedeon Richter or any dividend paying entity, namely:

(1) Price

(2) Dividends

(3) Returns

Those keys also show if any company has made, is making, and will make money.


GEDSF Price

GEDSF’s price was flat for the year as of Monday’s closing market price, at $24.85.


GEDSF Dividends

GEDSF has paid variable annualy dividends since June, 2017.

The current forward looking annual dividend of $1.17 yields 4.70% per Monday’s closing market price.


GEDSF Returns

Putting it all together, a $2.47 estimated gross gain per share shows up when adding GEDSF’s annual $1.17 dividend to an estimated $1.30 annual price gain, totaling that $2.47 gross gain.

A little under $1000 invested at the recent $24.85 price would buy 40 shares which, multiplies the $2.47 gross gain to $98.80.

Furthermore almost one-half of that $99 gain comes from the $47.00 in dividends generated from a $1,000 investment, and the $47.00 amounts to about $1.9 times more than the recent $24.85 single-share price.

(A dividend dogcatcher rule is to never buy a dividend from $1000 invested that pays less than the cost of a single share.)

Therefore, you may choose to pounce on Chemical Works of Gedeon Richter and its 4.7% dividend yield along with its 7 year dividend record.

The exact track of GEDSF’s future prices and dividends will entirely be determined by market action and company finances.  

Remember the best way to track stock performance and dividend payments is through direct ownership of company shares.


More By This Author:

Stocks Analysis: Bristol-Myers Squibb
Stock Analysis: Traton
Stock Analysis: Tokyo Century

Disclaimer: This article is for informational and educational purposes only and should not be construed to constitute investment advice. Nothing contained herein shall constitute a solicitation, ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
Or Sign in with